Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00103428
Recruitment Status : Terminated
First Posted : February 9, 2005
Last Update Posted : February 2, 2006
Information provided by:
Cell Genesys

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : No date given